Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Enhanced Bioavailability of Paclitaxel by Bamboo Concentrate Administration

  • Published : 2005.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study was to investigate the effect of a cotreatment of bamboo concentrates (Jukcho solution; 0.75, 1.5, and 3.0 mL/kg) with the chemotherapeutic agent paclitaxel on the bioavailability of orally administered paclitaxel (50 mg/kg) in rats. The effect of a pretreatment of bamboo concentrates (1.5 and 3.0 mL/kg for 1.0 h or a consecutive 3 day) was also examined. The paclitaxel plasma concentrations of rats orally administered paclitaxel plus bamboo concentrates (coadministration, 3.0 mL/kg and pretreatment, 1.5 and 3.0 mL/kg) were significantly higher than those of rats treated with paclitaxel alone. Plasma concentrations of paclitaxel in groups pretreated with bamboo concentrates for 3 day were markedly higher than those of a paclitaxel control group at the measured time points. The areas under plasma concentration-time curves (AUCs) of paclitaxel in groups pretreated with bamboo concentrates were elevated and the absolute bioavailability ($AB\%$) and relative bioavailability ($RB\%$) of paclitaxel were also significantly higher than those in the control group. The peak concentration ($C_{max}$), half-life ($t_{1/2}$), and the elimination rate constant ($K_{el}$) of paclitaxel after 3 day of pretreatment with bamboo concentrates were also significantly higher than those in the control, but the time required to reach the maximum plasma concentration ($T_{max}$) of paclitaxel was unaffected by the bamooo concentrates. Western blot analyses demonstrated that the level of CYP3A4 was increased in the livers of rats treated orally with paclitaxel, but this was reversed by pretreating with bamboo concentrates. These results show that bamboo concentrates enhance the bioavailability of orally administered paclitaxel and this effect may be associated with a diminished expression of CYP3A4 in the liver.

Keywords

References

  1. Cresteil, T., Monsarrat, B., Alvinerie, P., Treluyer, J. M., Vieira, I., and Wright, M., Taxol metabolism by human liver microsomes: Identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res., 54, 386-392 (1994)
  2. Fujitaka, K., Oguri, T., Isobe, T., Fujiwara, Y., and Kohno, N., Induction of cytochrome P450 3A4 by docetaxel in peripheral mononuclear cells and its expression in lung cancer. Cancer Chemother. Pharmacol., 48, 42-46 (2001) https://doi.org/10.1007/s002800100291
  3. Gan, L. S. L., Moseley, M. A., Khosla, B., Augustijns, P. F., Bradshaw, T. P., Hendren, R. W., and Thakker, D. R., CYP3A-Like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells: interaction between the two biochemical barriers to intestinal transport. Drug Metab. Dispos., 24, 344-349 (1996)
  4. Gidoh, M., Tsutsumi, S., Kaniwa, S., Narita, M., Matsumura, J., Takitani, S., and Fukushi, K., Studies on search for a promising immunopotentiative substance for treatment of leprosy. (I) Analytical studies on bamboo grass. Nippon Rai Gakkai Zasshi, 49, 38-46 (1980) https://doi.org/10.5025/hansen1977.49.38
  5. Holmes, F. A., Walters, R. S., Theriault, R. L., Forman, A. D., Newton, L. K., Raber, M. N., Buzdar, A. U., Frye, D. K., and Hortobagyi, G. N., Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J. Natl. Cancer Inst., 83, 1797-1805 (1991)
  6. Hu, C., Zhang, Y., and Kitts, D. D., Evaluation of antioxidant and prooxidant activities of bamboo Phyllostachys nigra var. Henonis leaf extract in vitro. J. Agric. Food Chem., 48, 3170- 3176 (2000) https://doi.org/10.1021/jf0001637
  7. Kim, K. K., Kawano, Y., and Yamazaki, Y., A novel porphyrin photosensitizer from bamboo leaves that induces apoptosis in cancer cell lines. Anticancer Res., 23, 2355-2361 (2003)
  8. Kim, S. G. and Cho, M. K., Expression of glutathione Stransferases Ya, Yb1, Yb2, Yc1 and Yc2 and microsomal epoxide hydrolase genes by thiazole, benzothiazole and benzothiadiazole. Biochem. Pharmacol., 52, 1831-1841 (1996) https://doi.org/10.1016/S0006-2952(96)00505-9
  9. Kuboyama, N., Fujii, A., and Tamura, T., Antitumor activities of bamboo leaf extracts (BLE) and its lignin (BLL). Nippon Yakurigaku Zasshi, 77, 579-596 (1981) https://doi.org/10.1254/fpj.77.579
  10. Kumar, G. N., Walle, U. K., and Walle, T., Cytochrome P450 3Amediated human liver microsomal taxol $6\alpha$-hydroxylation. J. Pharmacol. Exp. Ther., 268, 1160-1165 (1994)
  11. Kumar, N., Taxol-induced polymerization of purified tubulin. Mechanism of action. J. Biol. Chem., 256, 10435-10441 (1981)
  12. Kweon, M. H., Hwang, H. J., and Sung, H. C., Identification and antioxidant activity of novel chlorogenic acid derivatives from bamboo (Phyllostachys edulis). J. Agric. Food Chem., 49, 4646-4655 (2001) https://doi.org/10.1021/jf010514x
  13. Lee, S. H., Yoo, S. D., and Lee, K. H., Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography. J. Chomatogr. B, 724, 357- 363 (1999) https://doi.org/10.1016/S0378-4347(98)00566-0
  14. Manfedi, J. J. and Horwitz, S. B., An antimitotic agent with a new mechanism of action. Pharmacol. Ther., 25, 83-125 (1984) https://doi.org/10.1016/0163-7258(84)90025-1
  15. Mase, H., Hiraoka, M., Suzuki, A., and Nakanomyo, H., Determination of New anticancer drug, Paclitaxel, in biological fluids by high performance liquid chromatography. Yakugaku Zasshi, 114, 351-355 (1994) https://doi.org/10.1248/yakushi1947.114.5_351
  16. McGuire, W. P., Rowinsky, E. K., Rosenheim, N. B., Grumbine, F. C., Ettinger, D. S., Armstrong, D. K., and Donehower R. C., Taxol: A unique antineoplasic agent with significant activity in advanced ovarian epithelial neoplasm. Ann. Intern. Med., 111, 273-279 (1989) https://doi.org/10.7326/0003-4819-111-4-273
  17. Rahman, A., Korzekwa, K. R., Grogan, J., Gonzalezs, F. J., and Harris, J. W., Selective biotransformation of taxol to $6\alpha$- hydroxytaxol by human cytochrome P450 2C8. Cancer Res., 54, 5543-5546 (1994)
  18. Rowinsky, E. K., Cazenave, L. A., and Donehower, R. C., Taxol: A novel investigational antimicrotubule agent. J. Natl. Cancer Inst., 82, 1247-1259 (1990) https://doi.org/10.1093/jnci/82.15.1247
  19. Sarosy, G., Kohn, E., Stone, D. A., Rothenberg, M., Jacob, J., Adamo, D. O., Ognibene, F. P., Cunnion, R. E., and Reed, E., Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer. J. Clin. Oncol., 10, 1165-1170 (1992) https://doi.org/10.1200/JCO.1992.10.7.1165
  20. Shin, H. Y., Na, H. J., Moon, P. D., Shin, T., Shin, T. Y., Kim, S. H., Hong, S. H., and Kim, H. M., Inhibition of mast celldependent immediate-type hypersensitivity reactions by purple bamboo salt. J. Ethnopharmacol., 91, 153-157 (2004) https://doi.org/10.1016/j.jep.2003.12.006
  21. Sonnichsen, D. S., Liu, Q., Schuetz, E. G., Schuetz, J. D., Pappo, A., and Relling, M. V., Variability in human cytochrome P450 paclitaxel metabolism. J. Pharmacol. Exp. Ther., 275, 566- 575 (1995)
  22. Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K., Borst, P., Nooijen, W. J., Bejinen, J. H., and van Tellingen, O., Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by Pglycoprotein in the intestine. Proc. Natl. Acad. Sci. USA, 4, 2031-2035 (1997) https://doi.org/10.1073/pnas.94.5.2031
  23. Tsunoda, S., Yamamoto, K., Sakamoto, S., Inoue, H., and Nagasawa, H., Effects of Sasa Health, extract of bamboo grass leaves on spontaneous mammary tumourigenesis in SHN mice. Anticancer Res., 18, 153-158 (1998)
  24. Wani, M. C., Taylor, H. L., Wall, M. E., Coggon P., and McPhail, A. T., Plant antitumor agnets. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc., 93, 2325-2327 (1971) https://doi.org/10.1021/ja00738a045
  25. Watkins, P. B., The barrier function of CYP3A4 and Pglycoprotein in the small bowel. Adv. Drug Deliv. Rev., 27, 161-170 (1996) https://doi.org/10.1016/S0169-409X(97)00041-0
  26. Yamaoka, K., Tanigawara, Y., Nakagawa T., and Uno, T., Pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobiodyn., 4, 879-885 (1981) https://doi.org/10.1248/bpb1978.4.879